FAScinate Therapeutics, Inc. Cleared for Phase 2 Clinical Trials of...

FDA Approves FAScinate’s Application for Phase 2 Trials with “KM-819” Treatment(PRWeb November 17, 2021)Read the full story at https://www.prweb.com/releases/fascinate_therapeutics_inc_cleared_for_phase_2_clinical_trials_of_companys_parkinsons_disease_treatment_with_approval_from_u_s_food_and_drug_administration/prweb18340255.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news